New allergy treatment shows promise in Real-World study
NCT ID NCT07427576
First seen Feb 28, 2026 · Last updated May 15, 2026 · Updated 10 times
Summary
This study tested an immunotherapy treatment (Clustoid® Max Forte) for people with dust mite allergies, including those with allergic rhinitis, asthma, or eye allergies. Researchers looked at 140 patients aged 5 to 65 who had been on the treatment for at least a year. They measured symptoms and medication use before and during treatment to see if the therapy helped control allergic reactions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clínica Doctor García Robaina
Santa Cruz de Tenerife, Canary Islands, 38002, Spain
-
Nuestra Señora de Candelaria
Santa Cruz de Tenerife, Canary Islands, 38010, Spain
Conditions
Explore the condition pages connected to this study.